28.12.2010.
Case report
Recurrent Malignant Hypertension Treated with Angiotensin II Receptor Blocker (ARB) and ACE Inhibitor
The prognosis of malignant hypertension without treatment is poor, with more than 80% mortality in two years. It is unusual to see it on more than one occasion in the same patient. We demonstrated clinical course, response to treatment and outcome of a patient presenting with recurrent malignant hypertension. In this patient, we did not see high re...
By Rok Accetto, Olga Pirc-Čerček, Andreja Marn-Pernat